MARISSA LACHAGA: Open Payments
NPI 1396397659 · HERMISTON, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $110 |
| SANOFI PASTEUR INC. | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Lundbeck LLC | 1 | $28 |
| PFIZER INC. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: UBRELVY, BEYFORTUS, CAPLYTA, REXULTI, QULIPTA, NURTEC ODT, GARDASIL 9, Rybelsus.
Industry payments across OR — which companies pay providers there.
